Procter & Gamble

At a glance

Procter & Gamble reported 2025 revenue of $84.28B, up 0.3% from $84.04B in 2024. Over 4 years since 2021 ($76.12B), that is growth of about 2.6% a year. Operating margin was 24.3%, up from 23.6% in 2021. 2025 was the highest revenue year in this period.

In the last 12 months 15 insiders reported 0 open-market purchases and 30 sales ($70.5M). None of the sales were flagged as 10b5-1 plan trades. The largest was a sale of $28.1M by Exec. Chairman of the Board Jon R Moeller on Feb 13, 2026.

Procter & Gamble filed 18 current reports (Form 8-K) in the last 12 months, most often for regulation fd disclosure (8), results of operations (4), other events (3) and officer or director change (2). The latest officer or director change was reported on Jul 29, 2026.

2 of the 20 investors tracked here held Procter & Gamble at the last quarter end, worth $847.1M combined. It is the largest weight for National Pension Service (Korea) (0.5% of its portfolio), followed by Bridgewater Associates (0.1%). Added: National Pension Service (Korea). Reduced: Bridgewater Associates.

Annual results

Fiscal year ends Jun 30 · incorporated in OH

Tracked investors holding (13F)

Weight is the share of each investor's portfolio, as of the quarter end.